The haptoglobin 1 allele correlates with white matter hyperintensities in middle-aged adults with type 1 diabetes

Diabetes

Volumn 64, Issue 2, 2015, Pages 654-659

  Costacou, Tina ^a   Rosano, Caterina ^a   Aizenstein, Howard ^b   Mettenburg, Joseph M ^b   Nunley, Karen ^a   Ferrell, Robert E ^c   Orchard, Trevor J ^a  

^a UNIVERSITY OF PITTSBURGH GRADUATE SCHOOL OF PUBLIC HEALTH   (United States)

^b UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF PITTSBURGH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HAPTOGLOBIN; HAPTOGLOBIN 1; HAPTOGLOBIN 2; HEMOGLOBIN A1C; LIPID; UNCLASSIFIED DRUG; GENETIC MARKER;

ADULT; ALLELE; ARTICLE; BRAIN ATROPHY; BRAIN SIZE; CEREBROVASCULAR DISEASE; CORPUS CALLOSUM; DIABETIC PATIENT; FEMALE; GENETIC MARKER; GENOTYPE; HEMOGLOBIN BLOOD LEVEL; HOMOZYGOSITY; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; LACUNAR STROKE; LIPID BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; NEUROIMAGING; PRIORITY JOURNAL; SEX DIFFERENCE; SYSTOLIC BLOOD PRESSURE; WHITE MATTER; WHITE MATTER HYPERINTENSITY; CEREBROVASCULAR ACCIDENT; GENETIC POLYMORPHISM; GENETIC PREDISPOSITION; GENETICS; METABOLISM; PATHOLOGY; RISK FACTOR;

ADULT; DIABETES MELLITUS, TYPE 1; FEMALE; GENETIC MARKERS; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HAPTOGLOBINS; HUMANS; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC; RISK FACTORS; STROKE; WHITE MATTER;

EID: 84921930229     PISSN: 00121797     EISSN: 1939327X     Source Type: Journal    
DOI: 10.2337/db14-0723     Document Type: Article

References (26)

1. Debette S, Markus HS. The clinical importance of white matter hyperintensities on brain magnetic resonance imaging: systematic review and metaanalysis. BMJ 2010;341:c3666
2. Dufouil C, Chalmers J, Coskun O, et al.; PROGRESS MRI Substudy Investigators. Effects of blood pressure lowering on cerebral white matter hyperintensities in patients with stroke: the PROGRESS (Perindopril Protection Against Recurrent Stroke Study) Magnetic Resonance Imaging Substudy. Circulation 2005;112:1644-1650
3. Staals J, Pieters BM, Knottnerus IL, et al. Haptoglobin polymorphism and lacunar stroke. Curr Neurovasc Res 2008;5:153-158
4. Staals J, Henskens LH, Delanghe JR, et al. Haptoglobin phenotype correlates with the extent of cerebral deep white matter lesions in hypertensive patients. Curr Neurovasc Res 2010;7:1-5
5. Levy AP, Roguin A, Hochberg I, et al. Haptoglobin phenotype and vascular complications in patients with diabetes. N Engl J Med 2000;343:969-970
6. Levy AP, Hochberg I, Jablonski K, et al.; Strong Heart Study. Haptoglobin phenotype is an independent risk factor for cardiovascular disease in individuals with diabetes: The Strong Heart Study. J Am Coll Cardiol 2002;40:1984-1990
7. Suleiman M, Aronson D, Asleh R, et al. Haptoglobin polymorphism predicts 30-day mortality and heart failure in patients with diabetes and acute myocardial infarction. Diabetes 2005;54:2802-2806
8. Roguin A, Koch W, Kastrati A, Aronson D, Schomig A, Levy AP. Haptoglobin genotype is predictive of major adverse cardiac events in the 1-year period after percutaneous transluminal coronary angioplasty in individuals with diabetes. Diabetes Care 2003;26:2628-2631
9. Cahill LE, Levy AP, Chiuve SE, et al. Haptoglobin genotype is a consistent marker of coronary heart disease risk among individuals with elevated glycosylated hemoglobin. J Am Coll Cardiol 2013;61:728-737
10. Langlois MR, Delanghe JR. Biological and clinical significance of haptoglobin polymorphism in humans. Clin Chem 1996;42:1589-1600
11. Costacou T, Levy AP. Haptoglobin genotype and its role in diabetic cardiovascular disease. J Cardiovasc Transl Res 2012;5:423-435
12. Costacou T, Ferrell RE, Orchard TJ. Haptoglobin genotype: a determinant of cardiovascular complication risk in type 1 diabetes. Diabetes 2008;57:1702-1706
13. Costacou T, Secrest AM, Ferrell RE, Orchard TJ. Haptoglobin genotype and cerebrovascular disease incidence in type 1 diabetes. Diab Vasc Dis Res 2014;11:335-342
14. Wagener DK, Sacks JM, La Porte RE, Macgregor JM. The Pittsburgh study of insulin-dependent diabetes mellitus. Risk for diabetes among relatives of IDDM. Diabetes 1982;31:136-144
15. Orchard TJ, Dorman JS, Maser RE, et al. Prevalence of complications in IDDM by sex and duration. Pittsburgh Epidemiology of Diabetes Complications Study II. Diabetes 1990;39:1116-1124
16. Wu M, Rosano C, Butters M, et al. A fully automated method for quantifying and localizing white matter hyperintensities on MR images. Psychiatry Res 2006;148:133-142
17. Borhani NO, Kass EH, Langford HG, Payne GH, Remington RD, Stamler J. The hypertension detection and follow-up program: Hypertension detection and follow-up program cooperative group. Prev Med 1976;5:207-215
18. Koch W, Latz W, Eichinger M, et al. Genotyping of the common haptoglobin Hp 1/2 polymorphism based on PCR. Clin Chem 2002;48:1377-1382
19. Levy NS, Vardi M, Blum S, et al. An enzyme linked immunosorbent assay (ELISA) for the determination of the human haptoglobin phenotype. Clin Chem Lab Med 2013;51:1615-1622
20. Vardi M, Blum S, Levy AP. Haptoglobin genotype and cardiovascular outcomes in diabetes mellitus - natural history of the disease and the effect of vitamin E treatment. Meta-analysis of the medical literature. Eur J Intern Med 2012;23:628-632
21. Cid MC, Grant DS, Hoffman GS, Auerbach R, Fauci AS, Kleinman HK. Identification of haptoglobin as an angiogenic factor in sera from patients with systemic vasculitis. J Clin Invest 1993;91:977-985
22. Zhao X, Song S, Sun G, et al. Neuroprotective role of haptoglobin after intracerebral hemorrhage. J Neurosci 2009;29:15819-15827
23. Rouhl RP, Van Oostenbrugge RJ, Damoiseaux JG, et al. Haptoglobin phenotype may alter endothelial progenitor cell cluster formation in cerebral small vessel disease. Curr Neurovasc Res 2009;6:32-41
24. Farrall AJ, Wardlaw JM. Blood-brain barrier: ageing and microvascular disease-systematic review and meta-analysis. Neurobiol Aging 2009;30:337-352
25. Ergul A, Alhusban A, Fagan SC. Angiogenesis: a harmonized target for recovery after stroke. Stroke 2012;43:2270-2274
26. Durham JT, Herman IM. Microvascular modifications in diabetic retinopathy. Curr Diab Rep 2011;11:253-264